125 related articles for article (PubMed ID: 35341784)
1. Combination of berberine and low glucose inhibits gastric cancer through the PP2A/GSK3β/MCL-1 signaling pathway.
Peng Z; Wangmu T; Li L; Han G; Huang D; Yi P
Eur J Pharmacol; 2022 May; 922():174918. PubMed ID: 35341784
[TBL] [Abstract][Full Text] [Related]
2. Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis.
Elgendy M; Cirò M; Hosseini A; Weiszmann J; Mazzarella L; Ferrari E; Cazzoli R; Curigliano G; DeCensi A; Bonanni B; Budillon A; Pelicci PG; Janssens V; Ogris M; Baccarini M; Lanfrancone L; Weckwerth W; Foiani M; Minucci S
Cancer Cell; 2019 May; 35(5):798-815.e5. PubMed ID: 31031016
[TBL] [Abstract][Full Text] [Related]
3. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways.
Zhang Q; Wang X; Cao S; Sun Y; He X; Jiang B; Yu Y; Duan J; Qiu F; Kang N
Biomed Pharmacother; 2020 Aug; 128():110245. PubMed ID: 32454290
[TBL] [Abstract][Full Text] [Related]
4. Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization.
Gao F; Yu X; Li M; Zhou L; Liu W; Li W; Liu H
Cell Death Dis; 2020 Feb; 11(2):143. PubMed ID: 32081857
[TBL] [Abstract][Full Text] [Related]
5. Akt signaling is associated with the berberine-induced apoptosis of human gastric cancer cells.
Yi T; Zhuang L; Song G; Zhang B; Li G; Hu T
Nutr Cancer; 2015; 67(3):523-31. PubMed ID: 25837881
[TBL] [Abstract][Full Text] [Related]
6. Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6.
Xu M; Ren L; Fan J; Huang L; Zhou L; Li X; Ye X
Life Sci; 2022 Feb; 290():120266. PubMed ID: 34968467
[TBL] [Abstract][Full Text] [Related]
7. Berberine inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in gastric cancer.
Wang J; Yang S; Cai X; Dong J; Chen Z; Wang R; Zhang S; Cao H; Lu D; Jin T; Nie Y; Hao J; Fan D
Oncotarget; 2016 Nov; 7(46):76076-76086. PubMed ID: 27738318
[TBL] [Abstract][Full Text] [Related]
8. Berberine retarded the growth of gastric cancer xenograft tumors by targeting hepatocyte nuclear factor 4α.
Li LL; Peng Z; Hu Q; Xu LJ; Zou X; Huang DM; Yi P
World J Gastrointest Oncol; 2022 Apr; 14(4):842-857. PubMed ID: 35582103
[TBL] [Abstract][Full Text] [Related]
9. NDRG2 Sensitizes Myeloid Leukemia to Arsenic Trioxide via GSK3β-NDRG2-PP2A Complex Formation.
Park S; Han HT; Oh SS; Kim DH; Jeong JW; Lee KW; Kim M; Lim JS; Cho YY; Hwangbo C; Yoo J; Kim KD
Cells; 2019 May; 8(5):. PubMed ID: 31121982
[TBL] [Abstract][Full Text] [Related]
10. Celastrol impairs tumor growth by modulating the CIP2A-GSK3β-MCL-1 axis in gastric cancer cells.
Wu J; Ye F; Xu T
Aging (Albany NY); 2023 Jul; 15(14):6894-6904. PubMed ID: 37470692
[TBL] [Abstract][Full Text] [Related]
11. GSK3β and MCL-1 mediate cardiomyocyte apoptosis in response to high glucose.
Su D; Zhao J; Hu S; Guan L; Li Q; Shi C; Ma X; Gou J; Zhou Y
Histochem Cell Biol; 2019 Sep; 152(3):217-225. PubMed ID: 31197456
[TBL] [Abstract][Full Text] [Related]
12. Acquired Resistance to FGFR Inhibitor in Diffuse-Type Gastric Cancer through an AKT-Independent PKC-Mediated Phosphorylation of GSK3β.
Lau WM; Teng E; Huang KK; Tan JW; Das K; Zang Z; Chia T; Teh M; Kono K; Yong WP; Shabbir A; Tay A; Phua NS; Tan P; Chan SL; So JBY
Mol Cancer Ther; 2018 Jan; 17(1):232-242. PubMed ID: 28978722
[TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibitory effect of berberine and d-limonene on human gastric carcinoma cell line MGC803.
Zhang XZ; Wang L; Liu DW; Tang GY; Zhang HY
J Med Food; 2014 Sep; 17(9):955-62. PubMed ID: 25045784
[TBL] [Abstract][Full Text] [Related]
14. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells.
Chang W; Zhang M; Meng Z; Yu Y; Yao F; Hatch GM; Chen L
Eur J Pharmacol; 2015 Dec; 769():55-63. PubMed ID: 26522928
[TBL] [Abstract][Full Text] [Related]
15. Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives.
Wang N; Tan HY; Li L; Yuen MF; Feng Y
J Ethnopharmacol; 2015 Dec; 176():35-48. PubMed ID: 26494507
[TBL] [Abstract][Full Text] [Related]
16. A novel kinase inhibitor, LZT-106, downregulates Mcl-1 and sensitizes colorectal cancer cells to BH3 mimetic ABT-199 by targeting CDK9 and GSK-3β signaling.
Yu Z; Du J; Zhao Y; Gao Y; Li Y; Zhao K; Lu N
Cancer Lett; 2021 Feb; 498():31-41. PubMed ID: 33129955
[TBL] [Abstract][Full Text] [Related]
17. Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway.
Guo XH; Jiang SS; Zhang LL; Hu J; Edelbek D; Feng YQ; Yang ZX; Hu PC; Zhong H; Yang GH; Yang F
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34643248
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines.
Iizuka N; Miyamoto K; Okita K; Tangoku A; Hayashi H; Yosino S; Abe T; Morioka T; Hazama S; Oka M
Cancer Lett; 2000 Jan; 148(1):19-25. PubMed ID: 10680588
[TBL] [Abstract][Full Text] [Related]
19. Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway.
Wang S; He B; Hang W; Wu N; Xia L; Wang X; Zhang Q; Zhou X; Feng Z; Chen Q; Chen J
J Alzheimers Dis; 2018; 65(4):1385-1400. PubMed ID: 30175975
[TBL] [Abstract][Full Text] [Related]
20. Berberine ameliorates neuronal AD-like change via activating Pi3k/PGCε pathway.
Wu N; Liu W; Wang J; Han Y; Ye Y; Liu X; Yu Y; Chen Q; Bao Y; Liu C
Biofactors; 2021 Jul; 47(4):587-599. PubMed ID: 33740285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
